156 related articles for article (PubMed ID: 34295442)
1. B16 Melanoma Cancer Cells with Higher Metastatic Potential are More Deformable at a Whole-Cell Level.
Ujihara Y; Ono D; Nishitsuji K; Ito M; Sugita S; Nakamura M
Cell Mol Bioeng; 2021 Aug; 14(4):309-320. PubMed ID: 34295442
[TBL] [Abstract][Full Text] [Related]
2. Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells.
Watanabe T; Kuramochi H; Takahashi A; Imai K; Katsuta N; Nakayama T; Fujiki H; Suganuma M
J Cancer Res Clin Oncol; 2012 May; 138(5):859-66. PubMed ID: 22297840
[TBL] [Abstract][Full Text] [Related]
3. Mechanophenotyping of B16 Melanoma Cell Variants for the Assessment of the Efficacy of (-)-Epigallocatechin Gallate Treatment Using a Tapered Microfluidic Device.
Nakamura M; Ono D; Sugita S
Micromachines (Basel); 2019 Mar; 10(3):. PubMed ID: 30934576
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
[TBL] [Abstract][Full Text] [Related]
5. Measuring Melanoma Nanomechanical Properties in Relation to Metastatic Ability and Anti-Cancer Drug Treatment Using Scanning Ion Conductance Microscopy.
Woodcock E; Gorelkin PV; Goff PS; Edwards CRW; Zhang Y; Korchev Y; Sviderskaya EV
Cells; 2023 Oct; 12(19):. PubMed ID: 37830615
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence probes in metastatic B16 melanoma membranes.
Schroeder F
Biochim Biophys Acta; 1984 Oct; 776(2):299-312. PubMed ID: 6477911
[TBL] [Abstract][Full Text] [Related]
7. Differences in expression of a variant actin between low and high metastatic B16 melanoma.
Taniguchi S; Kawano T; Kakunaga T; Baba T
J Biol Chem; 1986 May; 261(13):6100-6. PubMed ID: 3700386
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of vinculin between weakly and highly metastatic B16-melanoma cell lines.
Sadano H; Inoue M; Taniguchi S
Jpn J Cancer Res; 1992 Jun; 83(6):625-30. PubMed ID: 1644665
[TBL] [Abstract][Full Text] [Related]
9. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
10. Differences in cytotoxic effects of activated murine peritoneal macrophages and J774 monocytic cells on metastatic variants of B16 melanoma.
Miner KM; Klostergaard J; Granger GA; Nicolson GL
J Natl Cancer Inst; 1983 Apr; 70(4):717-24. PubMed ID: 6339778
[TBL] [Abstract][Full Text] [Related]
11. Cell surface sialylation and tumor metastasis. Metastatic potential of B16 melanoma variants correlates with their relative numbers of specific penultimate oligosaccharide structures.
Passaniti A; Hart GW
J Biol Chem; 1988 Jun; 263(16):7591-603. PubMed ID: 3372501
[TBL] [Abstract][Full Text] [Related]
12. Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma.
Sadano H; Shimokawa-Kuroki R; Taniguchi S
Jpn J Cancer Res; 1994 Jul; 85(7):735-43. PubMed ID: 8071115
[TBL] [Abstract][Full Text] [Related]
13. Role of thymosin beta4 in tumor metastasis and angiogenesis.
Cha HJ; Jeong MJ; Kleinman HK
J Natl Cancer Inst; 2003 Nov; 95(22):1674-80. PubMed ID: 14625258
[TBL] [Abstract][Full Text] [Related]
14. Connexin 45 is a novel suppressor of melanoma metastasis.
Saito M; Tokunaga N; Saito T; Hatakenaka T; Sasaki T; Matsuki N; Minagawa S
Cytotechnology; 2023 Apr; 75(2):103-113. PubMed ID: 36969569
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
16. HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress.
Lee JJ; Park IH; Rhee WJ; Kim HS; Shin JS
FASEB J; 2019 Oct; 33(10):10942-10953. PubMed ID: 31284735
[TBL] [Abstract][Full Text] [Related]
17. Newly identified type of beta actin reduces invasiveness of mouse B16-melanoma.
Sadano H; Taniguchi S; Baba T
FEBS Lett; 1990 Oct; 271(1-2):23-7. PubMed ID: 2226807
[TBL] [Abstract][Full Text] [Related]
18. Identification of metastasis-related genes by genomic and transcriptomic studies in murine melanoma.
Kadioglu O; Saeed MEM; Mahmoud N; Hussein Azawi SS; Rincic M; Liehr T; Efferth T
Life Sci; 2021 Feb; 267():118922. PubMed ID: 33358905
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
[TBL] [Abstract][Full Text] [Related]
20. IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.
Zöller M
Clin Exp Metastasis; 1988; 6(5):411-29. PubMed ID: 3132343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
